Estrella Immunopharma Inc - Warrants (29/09/2028)
ESLAW
Get informed when a big investor buys or sells
+ FollowMarket Cap$31.37M
Close$
$0.04
46.1% downside
Current Fair Value
46.1% downsideOvervalued by 46.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $31.37 Million |
|---|---|
| Enterprise Value | $31.23 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.35 |
| Beta | -0.09 |
| Outstanding Shares | 42,997,733 |
Return
| Return on Equity | 134.74% |
|---|---|
| Return on Assets | -548.74% |
| Return on Invested Capital | 130.29% |
Valuation & Multiples
| P/E Ratio | -2.99 |
|---|---|
| PEG | 5.11 |
| Price to Sales | - |
| Price to Book Ratio | -0.07 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -3.23 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
September 2, 2026
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 30,0000% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.18%▼ 0.20% |
|---|---|
| Total Invested | $37,165▲ 41.86% |
| Investors Holding | 9▼ 1.00% |
ESG Score
No data